Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue 
Venezuela Promises Elections as Delcy Rodriguez Pledges Democratic Transition 
US Officials Split Over Response to Israeli West Bank Settlements 
Netanyahu Takes Aim at Mamdani as Israel Election Nears 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
FDA Weighs Safety Standards for Psychedelic Therapies 
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 
Taiwan Thanks US for Support Ahead of Trump-Xi Summit 
U.S. Issues Cuba Health Alert as Illnesses Rise 
Gaza Faces Evacuation Crisis as War-Damaged Buildings Risk Collapse 
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility? 
FCC Approves Foreign Investment in $110B Paramount-Warner Bros. Deal 
Sudan Rejects US Legitimacy Remarks, Defends Sovereignty 
Trump, Xi Focus on Trade and AI at White House Summit 
Trump Asks Supreme Court to Restore Third-Country Deportations 
Add as a preferred source on Google
U.S. Health Secretary Robert F. Kennedy Jr. told lawmakers this week that he is open to sharing details about David Geier’s contract with the Department of Health and Human Services (HHS), signaling growing scrutiny over the controversial appointment. During a Senate Finance Committee hearing, Kennedy stated that the contract could be provided to senators before the end of the week, offering what may become the first clear explanation of Geier’s responsibilities within the agency.
David Geier, known for his long-standing anti-vaccine activism, is currently working as a contractor tied to the Centers for Disease Control and Prevention (CDC). According to federal records, he is listed as a senior data analyst within the HHS system. His involvement has raised concerns among lawmakers and public health experts, particularly given his history of promoting debunked claims linking vaccines to autism.
Senator Ben Ray Luján of New Mexico pressed Kennedy on whether the administration would also release the protocols guiding Geier’s work. Kennedy responded that such protocols are not yet in place but promised they would be shared once the vaccine safety review is completed. Kennedy has previously indicated that Geier is leading a review of CDC vaccine data, a move that has sparked debate due to Geier’s controversial background.
Geier’s past actions have added to the concern. He was previously fined in Maryland for practicing medicine without a license and for administering unsafe treatments to children with autism. Critics argue that his involvement in federal health initiatives could undermine public trust in vaccine safety.
The situation highlights ongoing tensions around vaccine policy, public health transparency, and the role of individuals with disputed scientific views in government positions. As pressure builds, the release of Geier’s HHS contract could play a key role in shaping public and political response to the administration’s handling of vaccine-related issues.
